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Behcet's Syndrome: Case Report and Literature Review
K. v. Venkatasubramaniam, MD* and Douglas R. Swinehart, MD**

Behcet's syndrome is a disease commonly found in japan
and in countries around the Mediterranean Sea. In the U.S.,
it is relatively uncommon. This report describes a 24-yearold Lebanese-American man with Behcet's syndrome who

presented with symptoms four months after he developed
arthritis and who had been initially diagnosed as having
incomplete
Reiter's syndrome. A literature review is
Included.

In 1937, a Turkish dermatologist, Hulusi Behcet, described
a triple syndrome consisting of recurrent, painful oral and
genital ulcers and recurrent ulcers of the eye. His original
description was based upon an examination of three patients (1). The syndrome is now recognized as a multisystemic disorder with mucocutaneous, ocular, intestinal,
articular, vascular, urogenital, and neurological involvement (2,3), and it is classified with other mucocutaneousocular syndromes, e.g., erythema multiforme and Reiter's
syndrome (4). The etiology remains unknown. No specific
diagnostic or therapeutic aid is known. The disease is
common in Japan and in the countries surrounding the
Mediterranean Sea, such as Turkey, Italy, Greece, Israel,
Lebanon, and other Arab lands. A few patients with this
syndrome have been diagnosed recently in England and
Germany. However, Behcet's syndrome is still an uncommon disease in the U.S. (5). This paper includes a report on
a Lebanese-American patient with Behcet's syndrome and
a complete literature review.

tients, for a prevalence rate of 0.67:1,000 persons (6,7).
More patients were found in the colder, northern parts of
Japan (6,7). This prevalence rate is about ten times greater
than that of northern England, where a survey done at
Yorkshire found 32 patients in a population of five million
(8). In the U.S., the prevalence rate for Olmstead County,
Minnesota was 1:300,000 persons (9). Current estimates in
Japan place the number of patients wfth Behcet's syndrome
at 11,000 (9). Interestingly, while the syndrome has been
found in Hawaii, none of the diagnosed patients were
Japanese or Japanese-Americans, despite the frequency of
the disease in Japan and the large Japanese population in
Hawaii (10,11).

Historical Background
The earliest description of Behcet's syndrome as an acute
endemic disease can be found in the writings of Hippocrates (12). Shigeta (1924), Adamantiadis (1931), and Whitewell (1934) described cases similar to Behcet's syndrome
which preceded Behcet's classic paper in 1937 (1,13-15),
from which the presently accepted name derives. Some
have used the terms complete, abortive, partial, or incomplete to describe the clinical pattems of Behcet's syndrome (9), and Lehner has suggested dividing it into two
major categories, the mucocutaneous or benign type and
the neuro-ocular type, which may have more serious consequences (16).

Epidemiology
In Japan, the number of patients with Behcet's syndrome
has increased dramatically since World War II. In 1972-73,
a nationwide survey yielded an estimated 7000-8500 pa-
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The Behcet's Disease Research Committee of Japan (1972)
developed diagnostic criteria (Table 1) which are more
useful for classification than forclinical discrimination (17).
The Committee proposed four major criteria for the diag-

** Former Resident, Department of Dermatology, Henry Ford Hospital
Address reprint requests to Dr. Venkatasubramaniam, Division of Rheumatology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, M l 48202

153

Venkatasubramaniam and Swinehart

TABLE I
Diagnosis of Behcet's Syndrome
Major Criteria

Minor Criteria

1. Mouth (apththous)
Ulcers

1. Arthritis
a. of major joints
b. arthralgias

2. Iritis (with hypopyon)

2. Vascular Disease
a. migratory superficial phlebitis
b. major vessel thrombosis
c. aneurysms
d. peripheral gangrene
e. retinal and vitreous
hemorrhage, papilledema

3. Genital Ulcers

3. Central Nervous System Disease
a. brain stem syndrome
b. meningomyelitis
c. confusional states

Skin Lesions
a. pyoderma
b. nodose lesions

4. Gastronintestinal Disease
a. malabsorption
b. colonic ulcers
c. dilated intestinal loops
5. Epididymitis

nosis of the complete syndrome, whereas articular, gastrointestinal, vascular, and nervous system involvement are
considered minor criteria because they are less frequent
(Table I). More recently, epididymitis and symptoms related
to other organ systems have also been added to this classification. The incomplete syndrome requires that three major criteria be present some of the time, that recurrent
hypopyon, iritis, or retinitis occur, accompanied by one of
the major criteria, or that at least one of two major criteria
with some minor criterion be present with clinical suspicion of the disease. It is important to realize that the
complete type is not necessarily more severe than the
incomplete (17).

vaccine. His medical history revealed that he had had a
bleeding duodenal ulcer four years earlier.
Examination revealed a thin man with normal vital signs
who was in acute discomfort. On his face was a deep ulcer
w i t h an erythematous halo on the left cheek, a few
erythematous macules on the palate, and a white pustule
on an erythematous base on the lower lip (Fig. 1). There
were nontender anterior cervical and inguinal lymph nodes
bilaterally. A trace of effusion was noted in the left knee
with good range of motion of all joints. Multiple painful
ulcerations were present on the penis and scrotum with no
evidence of balanitis (Fig. 2). His physical examination was
otherwise normal.
Laboratory studies revealed a hemoglobin of 11 gms %, a
mean corpuscular volume (MCV) of 80, total ironbinding
capacity (TIBC) 2 7 6 , and a serum iron of 60. The
erythrocyte sedimentation rate (ESR) (Westergren) was 70
mm per hour. The reticulocyte count was 1.3%, rheumatoid factor negative, VDRL test nonreactive, and the
H L A - B 2 7 w a s positive. Urinalysis, serum multiphase
screen, and chest x-ray were normal. The upper gastrointestinal x-rays revealed only a spastic duodenal bulb. Xrays of the knee, lumbosacral spine, and pelvis were
normal, as was an ophthalmologic examination.

Case Report
A 24-year-old native American-born Lebanese man experienced recurrent painful oral ulcerations for two years.
About four months before his first visit to Henry Ford
Hospital, he noted left knee pain with swelling and subsequently developed pain in the right knee, ankles, feet,
elbows, and low back. An incorrect diagnosis of Reiter's
syndrome was made. Although the mucocutaneous lesions
were p a i n f u l , the patient improved on 100 mg Indomethacin daily. He was referred to the Rheumatology
Clinic of Henry Ford Hospital in August 1978 because he
had arthralgia and painful skin ulcerations on the shaft of
the penis and scrotum that had been unresponsive to
neosporin ointment, parenteral penicillin, and smallpox

Fig. 1
Ulcers on the palate suggest Behcet's syndrome.
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Fig. 3
Penile skin biopsy showing an inflammatory cellular infiltration of
mononuclear cells located between the collagen bundles and in close
apposition to the blood vessels (H & E 150 X).

Skin ulcerations in the peno-scrotal region.

Because we suspected Behcet's syndrome, the patient was
hospitalized for further tests. A biopsy from an ulceration of
the scrotum revealed that the central portion of the epidermis was completely eroded and the margins were acanthotic. A dense inflammatory infiltrate throughout the dermis
was composed of leukocytes, lymphocytes, plasma cells,
and histiocytes (Fig. 3). Numerous scattered dilated vessels
were seen in the upper dermis. Some vessels in the middermis showed endothelial cell proliferation and an invasion by mononuclear cells. Many vessels were completely
occluded. These changes were consistent with the ulcers of
Behcet's syndrome. Domeboro compresses were applied
to the open lesions along with Lidex in orabase ointment
four times a day. Indocin (100 mg daily) was continued. The
ulcers completely healed in six days.

Metereologic factors have also been claimed as a cause,
based chiefly on evidence suggesting its greater prevalence
in colder climates and the greater frequency of attacks in
Japan during the windy season. Hereditary factors are also
implicated. The association between the HLA-B5 antigen
and Behcet's syndrome is particularly strong in Japan and
Turkey, the two countries of greatest prevalence. HLA-A2
and HLA-B27 but not B5 was increased in a series from
Yorkshire (U.K.), whereas HLA-B27 was not present in a
recent American study of Behcet's syndrome (5,8,9,18-21).
One theory is that Behcet's syndrome is an autoimmune
disorder, since a patient's autoreactive antibody against
oral mucous membranes has been detected in serum. This
belief has been supported by recent immunofluorescence
studies demonstrating the deposition of IgM, IgG, and beta
IA globulin in the vessel walls of patients with Behcet's
syndrome. The elevated serum complement levels (Cl, C4,
C2 and C3), raised serum IgG, IgM and IgD, proportionate
increase of T lymphocytes and suppression of B lymphocytes in patients with Behcet's syndrome all lend further
credibility to the immunologic theory. The report of a
macrophage migration inhibitory factor in the anterior

Etiopathogenesis
The etiopathogenesis of Behcet's syndrome is complex and
intriguing. The cause is still obscure, but a sequence of
immunologic events has been implicated, perhaps precipitated by genetic, viral, toxic, and allergic factors.
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chamber of the eye in Behcet's syndrome suggests that cellmediated immunity might play a significant role (9).

subcutaneous venules of the extermities. Less commonly,
migrating obi iterative thrombophlebitis has been known to
occur (23).

The immunologic and immunochemical findings in neurological forms of Behcet's syndrome are important. Demyelinating antibodies, similar to those found in multiple
sclerosis, are detectable in more than 70% of patients with
Behcet's syndrome and neurologic involvemenL While the
antibodies in multiple sclerosis cause inhibition and destruction ofthe myelin, those in Behcet's syndrome do not
appear to inhibit myelinization. Furthermore, an antimyelin serum factor (AMSE) has been reported recently in
the serum and spinal fluid of patients with neuro-Behcet's
syndrome during the acute and active phase. A less specific
factor known as the cerebroside-binding serum factor
(CBSF) has also been detected. The elevation of CSF-lgA,
alpha-ll macroglobulin, and C3 in patients with neuroBehcet's syndrome is useful in assessing its severity. These
findings seem to support the concept that an immunologic
mechanism might play a significant role in the development of the vascular and neurologic manifestations of
Behcet's syndrome (7).

Acneiform skin eruptions resembling acne vulgaris appear
frequently on the face, neck, breast, and back. Uncharacteristically, some lesions can become pustular, but pruritis
is rare (23).
Abnormal hyper-irritability o f t h e skin against nonspecific
stimulation is found in 60-70% of patients who have
Behcet's syndrome; however, it is not specific for the
disorder (10,24,25). In areas where the syndrome is prevalent, a test that uses an aseptic needle to prick the skin can
be extremely helpful in diagnosis. The patient will develop
a tuberculin-like reaction with erythema and swelling at
the injection site 24-48 hours later; aseptic pustules will
develop later. The above reaction can be induced by
injection of physiologic saline, the patient's saliva, or the
aseptic extract of a genital ulcer. Although the mechanism
ofthis phenomenon is not known, it is thought to be related
to increased chemotaxis.

The vascular lesions show fragmentation and splitting of
the elastic fibers in the media and degeneration of the vasa
vasorum associated with perivascular round cell infiltration, while those in the nervous system include the vascular
changes described above as well as areas of diffuse demyel in ization and axonal degeneration.

Ocular lesions
The most serious problem in Behcet's syndrome is ocular
lesions, which involve recurrent episodes of anterior and
posterior uveitis sometimes leading to lossof vision. Hypopyon iritis, resulting from anterior uveitis, is atypical, often
transient sign, lasting only a few days. Further ocular
changes usually follow, with resultant recurrent posterior
uveitis, bleeding and exudate formation in the choroid and
retina. In a more advanced stage, loss of vision occurs
secondary to optic atrophy, glaucoma, and cataract. Very
rarely, phthisis bulbae might develop. It usually takes about
five years from the onset of ocular symptoms for the patient
to lose eyesight completely. Severe ocular involvement
seems to be more characteristic of Japanese patients with
Behcet's syndrome than of other nationalities (26).

Clinical Features
Aphthous ulcers
Recurrent aphthous ulcers occur on the mucous membranes of the lips, gingiva, cheeks (buccal mucosa), and
tongue. The palate, tonsils, and pharynx are rarely involved. Initially, a red, raised area appears that later becomes a shallow, round, or oval ulcer with erythematous
borders. A white or yellowish pseudo-membrane generally
covers the surface of this ulcer. Rarely, the ulcers may fuse
to form a single large ulcer. Most aphthous ulcers heal
without scarring except for those which fuse. In general,
these ulcers tend to occur in crops and recur often (9,16).

Genital lesions
Aphthous ulcers similar to those in the mouth occur most
frequently on the scrotum and vulva and less commonly on
the penis, perianal and vaginal mucosa. Genital ulcers are
deeper than the oral and may cause scarring. Because the
genital lesions in men tend to be more painful, they are
more apt to be discovered by the patient. Epididymitis,
which is frequently recurrent, has been reported in 4.5-8%
of male patients (9).

Skin lesions
Erythema nodosum lesions may occur on the lower extremities and are less commonly seen on the face, neck,
and buttocks. The lesion appears as an erythematous,
elevated lesion, with subcutaneous induration and tenderness. They tend to recur but are generally self-limiting (2).

Articular manifestations
A little over 50% of patients with Behcet's syndrome will
develop articular symptoms. The joint involvement is frequently recurrent, asymmetric, and characterized by pain.

Thrombophlebitis in the subcutaneous tissues is known to
occur, especially in men, and commonly involves the
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redness, and swelling. The knee is the most frequently
involved joint, while the ankle, elbow and wrist are less
frequently affected. The arthritis is seldom destructive. In
contrast to Reiter's syndrome, the sacroiliac joint is seldom
involved in Behcet's syndrome. Only 0.5-1% of the Japanese patients showed sacroiliac joint involvement. The
rheumatoid factor is negative in almost all cases. Rare cases
of erosive arthritis and osteonecrosis of the femur have
been documented (23,27-30).

recognized in Japan. It is usually associated with a poor
prognosis. Meningeal disease could mimic the features of
microbial meningitis. Vascular occlusions could involve
the cerebral or vertebrobasilar circulation, while parenchymatous involvement leading to brain stem, cerebellar, and spinal long tract damage have also been well
described. Psychological changes, characterized by amnesia, dementia and personality disturbances, are present
in at least 50% of cases (39-42).

Diagnosis and Treatment

Gastrointestinal and hepatic manifestations

The diagnosis of this condition remains syndromic. In
addition to the clinical findings, several nonspecific laboratory abnormalities support the diagnosis. These include the
increase of serum mucoproteins, reduced albumin, increased globulin, elevated erythrocyte sedimentation rate,
increased serum concentrations of IgG, IgM and IgD, elevated serum glycoproteins and sialic acid, leukocytosis,
and positive tests for C-reaction protein. In addition, circulating antibodies against human mucosal cells and lymphocytotoxicity to oral epithelial cells have also been found.
Most of the abnormalities are detected during the acute
attacks and diminish or disappear during remissions (9).

Gastrointestinal symptoms, which may occur in about 50%
of patients, include vomiting, abdominal pain, flatulence,
diarrhea, and constipation. Malabsorption and maldigestion are common. Ulcerations have been known to occur
in the terminal ileum and caecum and could lead to
perforation and fissure formation. In general, ulcerative
lesions tend to occur more frequently in Japanese patients
and carry a poor prognosis. Congestive changes in the liver
secondary to occlusion of the hepatic vein (Budd-Chiari
syndrome) have also been identified (9,31,32).
Cardiovascular manifestations

The "needle reaction" is one ofthe most reliable methods
for diagnosis but is unfortunately not present in all patients.
Rosettes of platelets around granulocytes may be detectable during the acute phase or during acute attacks and may
point to the diagnosis. However, this phenomenon is calcium-dependent and thereby demonstrable only in edeticacid (EDTA) anticoagulated blood (24,25,43).

Although cardiac involvement is rare, vascular involvement is much more frequent, severe, and can sometimes be
fatal. Four types of vascular lesions are recognized: venous
occlusions, arterial occlusion, aneurysm, and varices. Vascular symptoms were identified in 7.7% of Japanese patients with Behcet's syndrome during a 1972 nationwide
survey. The leading cause of death in Behcet's syndrome in
Japan was due to the rupture of a large artery aneurysm
(7,11,33). Venous lesions are generally more common than
arterial lesions.

Differential diagnosis
The most important diseases which mimic some of the
mucocutaneous clinical features of Behcet's syndrome include 1) Reiter's syndrome, 2) Stevens-Johnson syndrome,
3) aphthous stomatitis, 4) syphilis, 5) erythema nodosum,
and 6) herpetic stomatitis. The joint manifestations should
be differentiated from those of Reiter's syndrome.

Occlusion of the subclavian artery frequently leads to
pulseless disease. Aneurysms o f t h e renal artery may lead
to hypertension, while peripheral arterial occlusion produces symptoms of intermittent c l a u d i c a t i o n . Cerebrovascular complications secondary to arterial occlusion
are well documented (33). Venous occlusions involving the
superior or inferior vena cava are frequently observed. The
Budd-Chiari syndrome has also been known to occur
(34-36).
Arteriography, venography, and thermography have been
used to study the different patterns of vascular involvement
(37). Generally, it occurs more often in men than in women
and is less common when ocular signs are present or
permanent (38).

Reiter's syndrome is characterized by a triad of urethritis,
conjunctivitis, and arthritis, as well as by mucocutaneous
lesions. The knee is also commonly affected, and the
sacroiliac joint and thoracolumbar spine are invariably
affected in longstanding cases. Behcet's syndrome is differentiated from Reiter's syndrome by the painful oral and
genital ulcerations, recurrent uveitis, and arthralgias rather
than arthritis and vasculitis. The lack of sacroiliac joint
involvement in Behcet's syndrome is an important point in
differentiation.

Central nervous system manifestations

Clinical course

Nervous system involvement in Behcet's syndrome, which
was first described in 1941, has been well defined and

In the typical case, oral aphthous ulcers appear first, followed by skin lesions, ocular and genital involvement. In
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most instances, nervous system and vascular compl ications
occur later. In most patients frequent attacks occur early in
the disease followed by a slowing of activity. Eye symptoms
tend to become chronic and eventually lead to loss of
visual acuity or to blindness.

episodic nor destructive. In the light of a high index of
suspicion clinically, these criteria would justify the diagnosis of incomplete Behcet's syndrome, which was consistent with the biopsy findings. His positive HLA-B27 antigen
is interesting, although a clear relationship between this
factor and Behcet's syndrome remains speculative. Our
patient may eventually develop ocular or other manifestations characteristic ofthis syndrome. As yet, the patient has
had no serious problems but eventually he might require
the therapeutic agents mentioned. His prognosis therefore
remains guarded.

Men appear to be affected more often than women (ratio
1.2 to 2). However, a female preponderance has been
noted in a series reported from the U.S. and the U.K. In
general, the younger the patient, the poorer the prognosis.
Young men usually have the worst prognosis (8,42,44). The
mucocutaneous lesions without ocular involvement are
relatively frequent in women over 45; this has been termed
the incomplete type of Behcet's syndrome.
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Management
The treatment of Behcet's syndrome is controversial and
difficult. Some aspects of therapy continue to be empirical
and palliative. Transfer factor has been used in some
studies and has had moderate-to-great effectiveness in
controlling some recalcitrant lesions and in reducing the
number of new lesions and new attacks. More recently,
immunosuppressive therapy has been recommended,
while immunostimulant drugs (e.g., Levamisole) have also
been used. Colchicine has been used in some cases, chiefly
because of its antichemotactic activity. In the past,
fibrinolytic drugs have also been used, chiefly to combat
the fibrinolytic deficiency. Corticosteroids have largely
been used as a palliative mode of therapy (9).

Discussion
In the U.S., Behcet's syndrome is still considered rather
uncommon (5,28), although Duffy, et al (44) believe that
the disease usually passes unrecognized and is not that
rare. They described clinical and immunologic findings in
10 patients with Behcet's syndrome. Other cases reported
in the U.S. include that of a 49-year-old woman with
uveitis, recurrent orogenital lesions, polyarthritis, and skin
lesions (30); a patient with recurrent pneumonia associated
with Behcet's syndrome that occurred over 13 years; a
patient with thrombophlebitis, skin lesions, diffuse pulmonary infiltrate, and severe hemoptysis (45); and a patient
with Behcet's syndrome and neurologic involvement (22).
Behcet's syndrome is a multisystemic disease. Our patient
presented with recurrent aphthous and genital ulceration,
two major criteria, and with arthritis that was neither
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